Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression

Behav Brain Res. 2020 Feb 17:380:112439. doi: 10.1016/j.bbr.2019.112439. Epub 2019 Dec 17.

Abstract

Chronic stress is depressogenic by altering neurotrophic and neuroinflammatory environments of the organism. The endocannabinoid system controls cognitive and emotional responses related with stress through the interaction with endocannabinoid receptors. β-Caryophyllene (BCP) is a CB2 agonist that exhibited anti-inflammatory, analgesic effects but minimal psychoactive effects. To test if BCP exhibits antidepressant-like action, animals were chronically restrained with additional stressors for 28 days, and BCP (25, 50, 100 mg/kg) was intraperitoneally injected once a day during the stress inflicting period. Then despair related behaviors and hippocampal expression of neurotrophic, inflammatory and cannabinoid receptor levels were measured. To test the effect of BCP on long-term depression, field potentials were measured during the application of lipopolysaccharide and low frequency stimulation. In the tail suspension test and forced swim test, chronic stress-induced despair behaviors were reduced by BCP. Also BCP improved the stress-related changes in the hippocampal expression of COX-2, BDNF, and CB2 receptor expression. In organotypic hippocampal slices, BCP reduced the lipopolysaccharide-induced intensification of the long-term depression. In conclusion, BCP improved chronic stress related behavioral and biochemical changes. These results suggest that BCP may be effective in treating depression and stress related mental illnesses.

Keywords: Cannabinoid 2 receptor; Depression; Restraint-stress; β-Caryophyllene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / pharmacology*
  • Behavior, Animal / drug effects*
  • Depression / drug therapy*
  • Depression / etiology
  • Depression / metabolism
  • Depression / physiopathology
  • Disease Models, Animal
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Male
  • Polycyclic Sesquiterpenes / administration & dosage
  • Polycyclic Sesquiterpenes / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Cannabinoid, CB2* / drug effects
  • Receptor, Cannabinoid, CB2* / metabolism
  • Restraint, Physical
  • Stress, Psychological / complications
  • Stress, Psychological / drug therapy*
  • Stress, Psychological / metabolism
  • Stress, Psychological / physiopathology

Substances

  • Antidepressive Agents
  • Cnr2 protein, rat
  • Polycyclic Sesquiterpenes
  • Receptor, Cannabinoid, CB2
  • caryophyllene